FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

SSM Health Care St. Louis DBA SSM St. Clare Health Center HYDROmorphone HCl 10 mg in 0 Recall

HYDROmorphone HCl 10 mg in 0

SSM Health Care St. Louis DBA SSM St. Clare Health Center · Fenton, MO

Risk level
Class II
Reported by FDA
Jun 7, 2023
Recall ID
D-0776-2023
Check your lot numberHow we source this data

Summary

SSM Health Care St. Louis DBA SSM St. Clare Health Center recalled HYDROmorphone HCl 10 mg in 0 starting May 9, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0776-2023 on Jun 7, 2023. Reason: CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess. Status: Ongoing.

Why it was recalled

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Product description

HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-0600-2

Lot numbers, UPCs & expiration codes

Lot #: 20230222-45AB24, BUD: 8/21/2023; Lot #: 20230110-058361, BUD: 7/9/2023; Lot #: 20221208-0F5483, BUD: 6/6/2023; Lot #: 20221109-45BA60, BUD: 5/8/2023; Lot #:20220929-523FD5, BUD: 3/28/2023; Lot#: 20220914-5D5AE0, BUD: 3/13/2023; Lot #: 220502-024, BUD: 10/29/2022; Lot #: 220510-035, BUD: 11/6/2022; Lot #: 220526-015, BUD: 11/22/2022; Lot#: 220811-010, BUD: 2/7/2023

Where it was sold

Product was distributed in Missouri.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0776-2023
Classification
Class II
Status
Ongoing
Recall initiated
May 9, 2023
FDA report date
Jun 7, 2023
Quantity
3,232 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
SSM Health Care St. Louis DBA SSM St. Clare Health Center

Original FDA data

Every field from FDA enforcement report D-0776-2023, exactly as published.

Show all FDA fields
City
Fenton
State
MO
Status
Ongoing
Country
United States
Event ID
92395
Address
1015 Bowles Ave
Code information
Lot #: 20230222-45AB24, BUD: 8/21/2023; Lot #: 20230110-058361, BUD: 7/9/2023; Lot #: 20221208-0F5483, BUD: 6/6/2023; Lot #: 20221109-45BA60, BUD: 5/8/2023; Lot #:20220929-523FD5, BUD: 3/28/2023; Lot#: 20220914-5D5AE0, BUD: 3/13/2023; Lot #: 220502-024, BUD: 10/29/2022; Lot #: 220510-035, BUD: 11/6/2022; Lot #: 220526-015, BUD: 11/22/2022; Lot#: 220811-010, BUD: 2/7/2023
Postal code
63026-2394
Report date
Jun 7, 2023
Product type
Drugs
Recall number
D-0776-2023
Classification
Class II
Recalling firm
SSM Health Care St. Louis DBA SSM St. Clare Health Center
Product quantity
3,232 syringes
Reason for recall
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
Voluntary / mandated
Voluntary: Firm initiated
Product description
HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-0600-2
Distribution pattern
Product was distributed in Missouri.
Recall initiation date
May 9, 2023
Initial firm notification
Letter
Center classification date
May 31, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0776-2023, published Jun 7, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls